Poor aqueous solubility remains one of the most difficult challenges in pharmaceutical development, affecting up to 90% of new chemical entities (NCEs) and over 40% of those in reformulation. Low solubility impairs dissolution, absorption, and pharmacokinetics, resulting in poor bioavailability, increased formulation complexity, and a higher risk ...
read more